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of brainstem tumour in childhood
Kimberley M. Docking∗, Elizabeth C. Ward and Bruce E. Murdoch
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Abstract. While the occurrence and management of brainstem tumours in children would not traditionally indicate potential
direct structural impact on classical language centres, recent theories have implicated some involvement of the brainstem in a
functional language and cognitive neural loop between the cerebellum and the cerebral hemispheres. Thus, the present paper
explored the impact of treatment for brainstem tumour on the general and high-level language abilities of six children treated for
brainstem tumour, in addition to phonological awareness skills. Group analysis revealed that children treated for brainstem tumour
demonstrated intact language and phonological awareness abilities in comparison to an age- and gender-matched control group.
Individual analysis revealed only one of six children treated for brainstem tumour revealed evidence of language disturbances,
with an additional child demonstrating an isolated mildly reduced score on one phonological awareness task. Language deficits
identified in a child treated with a combination of both radiotherapy and chemotherapy were noted in the high-level language area
of lexical generation. Findings highlighted that no overt language disturbances were evident in children treated for brainstem
tumour. However, further analysis into higher-level language skills in the present study indicated that both general and high-level
language abilities require long-term monitoring in this population.
Keywords: Language, brainstem, tumour, children
1. Introduction
Tumour formation within the brainstem accounts for
10–20% of all central nervous system tumours in the
paediatric population [11,12,22,33,41,51,53,58]. They
frequently arise from the pons, and infiltrate the mid-
brain, medulla, the cerebellum and/or the fourth ventri-
cle [4,7,8,11,12,22,33,41,51,53,58]. The potential for
these tumours to have an impact on language function
has been recently highlighted, with authors proposing
theoretical involvement of the brainstem in cognitive
and language function.
Leiner and colleagues [31] described the participa-
tion of the brainstem in the neural network of informa-
tion passing from the cortex to the cerebellum. They
outlined that the descending projection of nerve fibres
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from Broca’s area in the cerebral cortex extends to the
red nucleus which sends its major output to the infe-
rior olive in the brainstem. In turn, the inferior olive is
connected to the dentate nucleus, which is connected
back to the red nucleus [31]. Thus, according to Leiner
et al. [31] a neural loop exists within the brainstem in
which the red nucleus receives a projection from lan-
guage areas of the cerebral cortex. This neural loop is,
therefore, proposed to participate in both language and
motor functions: in the cognitive processes of word-
finding, and the motor processes of expression; thereby
functioning as a language-learning loop [31]. Leiner et
al. [31] also described a larger projection than that from
the cerebral cortex to the red nucleus. That is, a cor-
tical projection to the pontine nuclei in the brainstem,
which also send information to the cerebellum [31],
previously established to be involved in language and
cognitive function. This proposed role played by the
brainstem in the pathways involved in language, there-
fore, highlights the potential for language impairment
when tumours of the brainstem arise and are treated in
childhood.
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Schmahmann [43] also attributed importance to the
brainstem in the cerebrocerebellar circuit involved in
language function. He outlined that input from brain-
stem structures that contain serotonin-, norepinephrine-
, and dopamine are a substantial source of cerebellar af-
ferents involved in this circuit. The involvement of the
brainstem in an adaptive control system model relating
to information representation and processing was also
discussed by Parkins [40].
According to Lalonde and Botez-Marquard [29], the
influence of the brainstem in cerebellar-related disor-
ders accounts for signs such as transitory mutism and
subsequent dysarthria following removal of midline
cerebellar tumours. Additionally, patients who present
with severe atrophy of the brainstem have been noted to
have significant recall deficits in auditory verbal learn-
ing tests [29]. Difficulties have also been noted in pa-
tients with combined cerebellar and brainstem dam-
age on neuropsychological tests involving recall and
sorting when compared to patients with selective cere-
bellar damage who did not exhibit difficulties. How-
ever, no difference was found in four mental tests by
heredodegenerative ataxia patients irrespective of the
presence of pontine damage [29]. Lalonde and Botez-
Marquard [29] believed that such results suggested a
test-selective involvement of the brainstem in the neu-
ropsychological deficits seen subsequent to cerebellar
atrophy. Barone et al. [5] also indicated that evidence
of the role of the brainstem (as with the cerebellum) in
the acquisition of non-motor cognitive functions, such
as verbal and performance intelligence, verbal learn-
ing, visuospatial memory and organization, has been
accumulating.
As previously outlined, the most extensive studies
into the communication abilities of children following
treatment for brain tumour to date have been carried out
by Murdoch, Hudson, and colleagues [24–26,35–38].
In examining the language abilities of twenty children
who had been treated for posterior fossa tumour, Mur-
doch and Hudson-Tennent [38] documented the only
known reported case in which the language abilities of
a child with brainstem involvement have been reported.
In the reported case, the tumour (an ependymoma) was
located in the vermis, but extended downwards into the
brainstem. The patient underwent subtotal surgical re-
moval at the age of two years one month, at which time
a ventriculoperitoneal shunt was also inserted, due to
the presence of obstructive hydrocephalus. Following
surgery, both radiotherapy and chemotherapy were ad-
ministered [38]. Chemotherapy involved eight cycles
of CCNU (Lomustine) (40 mg on day 1), procarbozine
(50 mg daily on days 8–21), and vincristine (7 mg on
days 8 and 29). Following treatment, this participant
was considered cured as no evidence of residual tumour
existed on a CT scan.
Findings from language assessments of this child re-
vealed performance within the average range on mea-
sures of general language abilities [38]. However, per-
formance in the Sentence Combining subtest of the Test
of Language Development – Intermediate was consid-
ered more than one standard deviation below the mean.
Results also indicated above average ability on tests
examining rapid language retrieval and production, and
confrontation naming. With the exception of one out
of five sections (Part IV) which was considered below
the normal range, the child also performed within the
normal limits on an assessment of auditory comprehen-
sion. Although these specific impairments were noted,
Murdoch and Hudson-Tennent [38] concluded in their
study that this case demonstrated relatively intact lan-
guage skills subsequent to treatment for a posterior
fossa tumour with brainstem involvement.
The case reported by Murdoch and Hudson-
Tennent [38] is the only report to date in which the lan-
guage abilities of a child with a brain tumour involving
the brainstem have been documented. In light of the
more recently developing theories regarding the poten-
tial role of the brainstem in language, it would follow
that a more thorough investigation of the language abil-
ities of children subsequent to treatment for a brain-
stem tumour is required. It is also noted that while the
test battery used by Murdoch and Hudson-Tennent [38]
included one test of high-level language (the Test of
Language Competence), the participant with brainstem
involvement attempted but was unable to complete this
assessment due to extreme difficulty understanding the
requirements of each subtest. Therefore, potential dif-
ficulties in higher-level language processing may have
gone undetected in this case. Particular investigation
of the high-level language abilities in this group of sub-
jects remains crucial given the documented impairment
in high-level abilities in children with acquired brain in-
jury [14,15,27] and the reported effects associated with
treatment for childhood brain tumour [35]. Information
is, however, particularly lacking in this area.
In addition to a comprehensive investigation of high-
level language abilities in children treated for brain-
stem tumour, phonological awareness skills providing
a foundation for literacy development have not previ-
ously been addressed, and therefore deficits in this area
may have also been overlooked. The investigation in
the present paper will, therefore, examine both the gen-
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eral and high-level language and pre-literacy abilities
of children who have received treatment for a brainstem
tumour in order to investigate the existence of language
impairment.
2. Methodology
2.1. Participants
Six participants, 4 female and 2 male, ranging in age
from 5 years 6 months to 14 years 11 months (mean
age = 9.51 years; standard deviation = 3.59 years),
who had completed treatment for a brain tumour in-
volving the brain stem 6 months or more previously
were included in the study. Four of the 6 participants
were managed and treated at the Mater Children’s Hos-
pital in Brisbane, Australia, with the remaining two
participants managed and treated at the Royal Chil-
dren’s Hospital, Brisbane, Australia. All participants
included were recruited through the respective Haema-
tology/Oncology departments of the above hospitals.
Biographical details of the participants are summa-
rized in Table 1. Six control participants individually
matched for age and gender (mean age = 9.50 years;
standard deviation= 3.56 years) were also included in
the study, all of whom had no previous history of can-
cer, acquired brain injury, epileptic activity or seizures
or speech/language difficulties.
All experimental and control participants spoke En-
glish as their first and only language.
2.2. Procedure
Language testing was carried out by the first author
over a number of sessions in each participant’s home,
to reduce the influence of fatigue for the child. Both
Case 1 and 2 underwent the first assessment session in
hospital-based accommodation (provided for families
who live outside the local area) and a quiet office in
the hospital ward, respectively, with each of the second
sessions carried out at the participants’ homes. While
the order was randomized to prevent fatigue effects the
test battery was divided into two sections: 1) general
language and 2) high-level language and pre-literacy.
2.2.1. General language assessments
Each of the 6 participants and their age- and gender-
matched peers were administered three assessments
of general language: either the Clinical Evaluation
of Language Fundamentals – Third Edition (CELF-
3) [44] or the Clinical Evaluation of Language Funda-
mentals – Preschool (CELF-P) [57], the Peabody Pic-
ture Vocabulary Test – Third Edition (PPVT-III) [18],
and the Hundred Pictures Naming Test (HPNT) [19].
The age of each participant at the time of testing de-
termined whether they were administered the CELF-
3 or the CELF-Preschool. Five participants and their
matched controls were administered the CELF-3 (for
children aged 6+ years of age).
2.2.2. High-level language and phonological
awareness assessments
Five of the 6 participants (Case 1,2, 4, 5 and 6) (mean
age = 10.32 years; standard deviation = 3.35 years)
and their corresponding age- and gender- matched peers
(mean age = 10.28 years; standard deviation = 3.35
years) were administered three assessments of high-
level language and one assessment of phonological
awareness. The following tests were included in the
test battery: Test of Problem Solving – Elementary,
Revised (TOPS-Elementary) [60] or Test of Problem
Solving – Adolescent (TOPS-Adolescent) [59], Test of
Word Knowledge (TOWK) [56], Test of Language Com-
petence – Expanded Edition (TLC-E) [55], and ei-
ther the Queensland University Inventory of Literacy
(QUIL) [16] or the Test of Phonological Awareness
(TOPA) [52]. Again, the age of each participant treated
for brainstem tumour and their individually matched
peer determined the version or age-group level that was
completed for each assessment.
While assessments of high-level language were not
administered to Case 3 as this participant was too young
to complete these assessments, the pre-literacy assess-
ment, the Test of Phonological Awareness (TOPA),
was carried out to determine the level of phonologi-
cal awareness abilities. Case 3 was administered this
assessment as she was below the school-age limit of
the QUIL assessment administered to the remaining 5
participants treated for brainstem tumour. Therefore,
as Case 3 was the only participant to complete this as-
sessment the TOPA was not included in the group sta-
tistical analysis. However, these results are discussed
in the individual case analyses.
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Table 3
Brainstem tumour and control group analysis: Means (M), Standard deviations (SD), and Mann
Whitney U comparisons for the Test of Problem Solving (TOPS), Test of Word Knowledge
(TOWK), Test of Language Competence - Expanded (TLC-E), and Queensland University
Inventory of Literacy (QUIL)
Parameter Brainstem group Control group Mann Asymp.
(n = 5) (n = 5) Whitney Sig. (2-
M SD M SD U tailed)
TOPS 107.40 10.78 108.60 13.13 12.5 1.00
TOWK
Receptive composite 106.60 10.04 110.20 10.09 10.0 0.60
Expressive composite 107.60 8.44 107.80 17.44 11.5 0.83
Total score 107.40 9.18 109.60 12.70 12.0 0.92
TLC-E
Interpreting intents 102.40 10.48 106.40 16.99 12.0 0.92
Expressing intents 100.60 14.91 109.60 14.29 6.5 0.21
Total score 101.40 11.33 109.60 16.43 8.0 0.34
QUIL
Nonword spelling 14.80 2.17 12.00 2.94 3.5 0.10
Nonword reading 12.60 2.97 9.75 3.86 7.0 0.45
Syllable identification 12.00 1.41 10.50 1.29 4.5 0.16
Syllable segmentation 11.40 1.95 10.2 1.26 5.5 0.25
Spoken rhyme 11.80 1.30 8.50 3.70 1.5 0.03
Spoonerisms 12.40 2.97 11.50 1.73 9.0 0.80
Phoneme detection 10.60 2.79 10.50 2.08 9.0 0.80
Phoneme segmentation 14.40 0.89 13.25 2.63 5.5 0.26
Phoneme manipulation 12.80 1.79 10.50 3.32 5.0 0.21
Note: p significant at< 0.05 for TOPS, TOWK, and TLC-E; p significant at< 0.01 for QUIL.
3. Results
Two levels of analysis were employed to determine
the presence of language disturbances in a group of
children treated for brainstem tumour consistent with
previous research methodology [38]. The first level
involved a statistical comparison between a group of
participants treated for brainstem tumour and the group
comprised of individually matched peers. The second
level of analysis involved a comparison of the indi-
vidual standard scores of each participant treated for
brainstem tumour to the normative data provided for
each assessment, accounting for any individual vari-
ability and potential individual language disturbances
that may have been overlooked in the statistical group
level comparison. Due to the heterogeneity of partic-
ipants, this level of analysis allowed an examination
of the language outcomes of each participant treated
for brainstem tumour in the context of individual tu-
mour presentations, treatments, age at diagnosis and
treatment, presenting symptoms, time post treatment at
which language testing occurred, and any other signif-
icant individual features.
3.1. Group analysis
Homogeneity of variance was tested across all pa-
rameters using the Levene’s Test for Equality of Vari-
ance, and was found to be non-significant (p > 0.05).
However, due to small group numbers conservative
analysis using non-parametric statistics was conducted.
Therefore, the Mann-Whitney U test was employed to
determine the presence of statistically significant dis-
crepancies across all parameters. Due to the multi-
plicity of subtests comprising the QUIL, a stringent al-
pha level of p < 0.01 was applied for this assessment
only [46]. For all other tests an alpha level of 0.05 was
adopted.
Due to the variation in age level across participants
ranging from 5 years 6 months to 14 years 11 months,
two different general language assessments, the CELF-
Preschool and the CELF-3, were completed accord-
ing to age, with differing age level subtests. Despite
two versions of the general language assessment having
been completed, the data was able to be collapsed as
the CELF-Preschool was designed as a downward ex-
tension of the original Clinical Evaluation of Language
Fundamentals – Revised (CELF-R) [45]. Subsequent
to publication of the CELF-Preschool, the CELF-R was
again revised and published as the Clinical Evaluation
of Language Fundamentals – Third Edition (CELF-3),
the version used for the older children in the present
study. Consequently, group statistics at a subtest level
was not possible, with only overall and total scores
compared in the group analysis.
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Table 4
Individual general language assessment results (represented in standard scores) of
Cases 1, 2, 4, 5, and 6 treated for brainstem tumour on the Clinical Evaluation of
Language Fundamentals – Third Edition (CELF-3), Peabody Picture Vocabulary
Test – Third Edition (PPVT-III), and the Hundred Pictures Naming Test (HPNT)
Tests Case 1 Case 2 Case 4 Case 5 Case 6
CELF-3
Receptive Language 131 125 104 125 112
Concepts and directions 17 12 8 16 16
Word classes 15 15 9 13 13
Semantic relationshipsb /
Sentence structurea 12b 15b 15b 13a 7a
Expressive language 120 106 116 104 114
Formulated sentences 12 12 15 12 15
Recalling sentences 12 12 13 10 9
Sentence assemblyb/
Word structurea 16a 9b 10b 10a 13a
Total language 126 116 110 115 113
PPVT-III 101 102 118 102 110
HPNT (Raw score/100) 97 99 100 94 96
Note: a = Level 1 subtest variation; b = Level 2 subtest variation; Standard
scores in italics = normal range 85–115; Subtest standard score normal range =
7–13.
As norms were not calculated for Grade 1 aged chil-
dren on the Visual Rhyme subtest of the QUIL, a stan-
dard score could not be calculated from the perfor-
mance of Case 5. Therefore, as the performance of
only four children constituted the group for this sub-
test, statistical tests could not be carried out. Group
analysis of performance on the Visual Rhyme subtest
is, therefore, not reported. However, it is included in
the individual case analysis. Additionally, as both Case
4 and the matched control participant were aged above
the upper limits of the normative data provided by the
QUIL (Grades 1–7) in Grade 9, individual standard
scores were calculated based on the Grade 7 normative
data.
Subsequent to statistical analysis, it was determined
that no significant differences (p > 0.05) were evi-
dent on measures of general language abilities between
a group of 6 participants who had been treated for
brainstem tumour and their individually matched peers
(see Table 2). Statistical comparison also revealed that
across performance on both the high-level language
and phonological awareness assessments, the group of
five participants (Cases 1, 2, 4, 5 and 6) treated for
brainstem tumour were not significantly different (p >
0.05) to those of their age- and gender-matched control
group across all subtests of the TOPS, TOWK, TLC-E,
and the QUIL (see Table 3).
3.2. Individual analysis
An individual analysis revealed one of six cases with
demonstrated reduced ability (Case 5) in some specific
aspects of language function, and an additional partic-
ipant noted to have an isolated weakness in one aspect
of phonological awareness (Case 2). The remaining
four participants were determined to function within
normal limits on all parameters. The individual case
presentations of all six children treated for brainstem
tumour are presented in the following case analyses.
3.2.1. Case 1
Case 1 was diagnosed with a lower brainstem/upper
cervical spinal cord low-grade astrocytoma (see Fig. 1),
following investigations into a left sided hemi-atrophy,
at the age of 8 years 7 months. No surgical resection
or debulking of the tumour was carried out. A 6 week
course of radical radiotherapy treatment (external beam
radiation) was commenced one month later, with a dose
of 54 Gy delivered in 30 fractions over the course of
treatment. The absence of clinical signs and a series of
follow-up Magnetic Resonance Imaging (MRI) scans
over the next nine to twelve months (including a scan
one day prior to language testing – see Fig. 2) demon-
strated no evidence of tumour progression. Based on a
number of thallium studies it was determined that the
tumour was no longer viable, and that the disease was
deemed stable.
Language testing for the study was carried out
eighteen months following completion of radiotherapy
treatment, at the age of ten years five months. Case 1
performed above the normal range for a child her age
on a measure of general receptive and expressive lan-
guage abilities (CELF-3), and on a confrontation nam-
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Table 5
Individual high-level language and phonological awareness assessment results (rep-
resented in standard scores) of Case 1, 2, 4, 5, and 6 treated for brainstem tumour
on the Test of Problem Solving (TOPS), Test of Word Knowledge (TOWK), Test of
Language Competence – Expanded (TLC-E), and Queensland University Inventory
of Literacy (QUIL)
Tests Case 1 Case 2 Case 4 Case 5 Case 6
TOPS 102 107 123 94 111
TOWK
Receptive composite 94 100 106 115 118
Synonymsb/
Word oppositesa 8b 10b 12b 11a 12a
Figurative usageb/
Receptive vocabularya 10b 10b 10b 14a 14a
Expressive composite 103 97 114 106 118
Word definitions 11 9 12 9 14
Multiple contextsb /
Expressive vocabularya 10b 10b 13b 13a 12a
Total langrage 98 98 111 111 119
TLC-E
Interpreting intents 88 97 115 103 109
Listening comprehension:
Making inferences 8 11 10 13 12
Figurative language 8 11 15 8 11
Expressing intents 100 103 100 79c 121
Ambiguous sentences 9 11 11 6∗ 11
Oral expression: Recreating
Sentencesb /Speech Actsa 11b 10b 9b 7a 16b
Total langrage 93 100 108 89 117
QUIL
Nonword spelling 15 16 16 11 16
Nonword reading 10 10 12 17 14
Syllable identification 11 11 11 14 13
Syllable segmentation 8 12 12 12 13
Spoken rhyme 11 11 11 14 12
Visual rhyme 12 12 12 ∗ 11
Spoonerisms 11 13 12 17 9
Phoneme detection 10 6c 12 13 12
Phoneme segmentation 15 15 13 15 14
Phoneme manipulation 13 11 11 15 14
Note: a = Level 1 subtest variation; b = Level 2 subtest variation; c = below
normal range (Standard scores in italics: normal range 85–115; Subtest standard
score normal range = 7–13); ∗ normative data not available for this child.
ing assessment (HPNT). Scores also within in the nor-
mal range on the PPVT – III highlight abilities that are
commensurate with a child of similar age in the area of
receptive vocabulary (see Table 4). Similarly, assess-
ments of high-level language and phonological aware-
ness revealed abilities that were considered within the
normal range (see Table 5).
3.2.2. Case 2
Case 2 was diagnosed with a low-grade astrocytoma
in the right pons extending into the middle cerebellar
peduncle (see Fig. 3), after presenting with a 2 month
history of poor balance, at the age of 9 years 11 months.
The tumour was regarded as well differentiated. No
surgical resection or debulking of the tumour was car-
ried out. A 6-week course of radical radiotherapy treat-
ment (external beam radiation) was commenced two
months later. An overall dose of 54 Gy was delivered
in 30 fractions over the treatment period.
Testing for the study was carried out 22 months fol-
lowing completion of radiotherapy treatment, at age 11
years 11 months to 12 years 0 months. While consid-
erable reduction of the tumour was noted in the initial
follow-up MRIs following radiotherapy, a MRI study
carried out 3 weeks prior to testing (see Fig. 4) indi-
cated that there had been no change in the size or ap-
pearance of the astrocytoma in the right middle cere-
bellar peduncle compared with the most recent study
prior. A minimal mass effect was also found, but was
restricted to right fourth ventricle. A thallium study
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Fig. 1. Case 1 at diagnosis: Sagittal and coronal MRI scans indi-
cating a lower brainstem/upper cervical cord low-grade astrocytoma.
Report indicated a large intramedullary tumour mass expanding the
cervical cord and extending from the level of C5/6 disc inferiorly to
the caudal medulla.
carried out 6–9 months earlier indicated a non-viable
tumour, deemed stable by the participant’s oncologist.
Performance on the general language battery of tests
revealed that Case 2 was positioned well within the nor-
mal range across all tests, including scores above the
normal range on the Receptive Language component
of the CELF-3, and on a test of confrontation naming
(HPNT) (see Table 4). Case 2 performed well within
the normal range across tests of high-level language
Fig. 2. Case 1 at language testing (18 months post treatment): T1
weighted coronal MRI scan of the brain post radiotherapy demon-
strating a cystic astrocytoma in cervicomedullary junction.
and phonological awareness compared to the norma-
tive data provided for each assessment (see Table 5).
While standard scores for nine of the ten phonological
awareness subtests were either in the high average to
above normal range for a child Case 2’s age, perfor-
mance on the Phoneme Detection subtest was noted to
be below the normal range. This isolated subtest deficit
indicated a difficulty detecting the word without the
same first/end/last/middle sound as the remaining three
words in the item.
3.2.3. Case 3
At the age of 2 years 5 months, Case 3 was diag-
nosed with an ependymoma involving both the third
ventricle and the brain stem (see Fig. 5) following a
4 week history of vomiting, headache, and irritabil-
ity. A 22 history of unsteady gait and ataxia was also
present. Case 3 was also reported to have a history of
head tilt to the right, as well as awakening and scream-
ing out during the night. An emergency third ven-
triculostomy was performed to relieve hydrocephalus
(of which papilloedema was also reportedly a symp-
tom), with subtotal resection and ventriculoperitoneal
shunt insertion 5 days later. Two weeks subsequent,
chemotherapy commenced. Cycle 1 utilized cisplatin
on day 1, with etoposide administered on days 1–21.
This cycle was repeated. Cycle 3 utilized the agents
cyclophosphamide, etoposide, and vincristine over 21
days. This cycle was also repeated. Radiotherapy
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Fig. 3. Case 2 at diagnosis: T1 weighted coronal MRI scan revealing
a 2× 2× 1.8 cm low-grade astrocytoma in far lateral aspect of pons
extending into the right middle cerebellar peduncle. Mild mass effect
with some effacement of the lateral ventricle.
treatment commenced approximately 3 weeks follow-
ing completion of the chemotherapy regime (8 months
subsequent to diagnosis). Posterior fossa irradiation
was administered with a local field boost (details of
exact dosage not available), twice daily over 5 weeks.
Language testing was carried out 2 years and
4 months following treatment completion, at the age
of 5 years 6 months (see Fig. 6). Case 3 performed
well within the normal range on general language tests
across both receptive and expressive subtests on the
CELF-Preschool. Additionally, confrontation naming
skills were demonstrated to be above the normal range
for a preschool aged child on the HPNT. A summary
of Case 3’s results are provided in Table 6. Although
Case 3 was not administered assessments of high-level
language, performance on the pre-literacy assessment,
the TOPA, represented performance that was within the
normal range with a standard score of 105.
3.2.4. Case 4
Case 4 was diagnosed at the age of 8 years 8 months
with a low grade pontine astrocytoma, arising at the
medullo-pontine angle posteriorly, extending into the
fourth ventricle and involving the middle cerebellar pe-
duncle on the right (see Fig. 7). A 3 year history of
right VIth cranial nerve palsy was noted, along with a
right VIIth cranial nerve palsy for 2 years. A CT head
scan performed three years prior to actual diagnosis did
Fig. 4. Case 2 at language testing (1 year 10 months post treatment):
Sagittal and coronal MRI scans demonstrating no interval change in
size or appearance of previously demonstrated astrocytoma in right
pons following radiotherapy treatment.
not reveal a tumour. Following diagnosis a total surgi-
cal excision was performed, leaving residual/persistent
right-sided lower motor neurone VI and VII cranial
nerve palsies. Dexamethasone was administered post-
operatively.
Six years and 3 months post treatment, at the age of
14 years 11 months, Case 4 participated in language
testing. A MRI study was carried out two days follow-
ing language testing (see Fig. 8). Case 4 performed
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Fig. 5. Case 3 at diagnosis: Coronal and axial MRI scans demon-
strating an ependymoma involving both the third ventricle and the
brainstem.
within the normal limits on a measure of general re-
ceptive and expressive language abilities when com-
pared with the standardized test normative data (see Ta-
ble 4). Receptive vocabulary as assessed by the PPVT-
III was considered intact, with a standard score above
the normal range yielded. Confrontation naming was
also considered to reflect ability in the normal range
for a child Case 4’s age. Case 4 also performed consis-
tently within the normal range on assessments of high-
level language and phonological awareness skills (see
Table 5).
3.2.5. Case 5
Case 5 presented at the age of 20 months with a de-
terioration of balance and was diagnosed with a 3.2 cm
brainstem glioma causing mild-moderate obstructive
hydrocephalus (MRI scan unavailable). Chemother-
apy was administered and the tumour was partially
controlled with tamoxifen, then lomustine (CCNU)
two years later, and etoposide the following year. Ra-
diotherapy was commenced 2 years 10 months follow-
ing diagnosis at the age of 4 years 2 months. Radical
radiotherapy (external beam radiation) to the brainstem
was administered using posterior oblique fields. A dose
of 54 Gy was delivered in 30 fractions over 6 weeks.
Dexamethasone was given at this time.
Language testing was administered at the age of
6 years 6/7 months (2 years following treatment). A
MRI study carried out 1 month following testing re-
Table 6
General language assessments results (represented in standard
scores) of Case 3 treated for brainstem tumour, on the Clinical Eval-
uation of Language Fundamentals - Preschool (CELF-Preschool),
Peabody Picture Vocabulary Test - Third Edition (PPVT-III), and the
Hundred Pictures Naming Test (HPNT)
Tests Case 3
CELF-Preschool
Receptive Language 114
Linguistic concepts 12
Basic concepts 13
Sentence structure 12
Expressive Language 94
Recalling sentences in context 10
Formulating labels 10
Word structure 7
Total language 103
PPVT-III 107
HPNT (Raw score/100) 90
Note: Standard scores in italics = normal range 85–115; Subtest
standard score normal range = 7–13.
vealed no interval change in the appearance of the tu-
mour compared to a previous follow-up scan, and ven-
tricular size and configuration within normal limits.
Posterior fossa and supratentorial structures were also
considered normal in appearance with no evidence of
radiation necrosis (see Fig. 9). Case 5 had a history
of speech pathology intervention following a referral
2 years subsequent to diagnosis. While general recep-
tive language abilities were consistently deemed to be
within normal limits, persisting word finding difficul-
ties were noted in the area of expressive language.
In the present study, Case 5 performed within normal
limits on a general measure of receptive and expressive
language abilities (the CELF-3), compared to the stan-
dardized test normative data. Receptive vocabulary as
measured by the PPVT-III indicated abilities in the nor-
mal range, with naming abilities on the HPNT found
to be above the normal range for a child in Grade 1 at
school. Case 5’s results are summarized in Table 4.
While Case 5 performed in the high to above the nor-
mal range on an assessment of phonological awareness
skills (QUIL), high-level language abilities reflected
some areas of weakness (see Table 5). Although perfor-
mance on both the TOPS-R Elementary and the TOWK
fell within the normal range, high-level language abili-
ties examined by the TLC-E (Level 1) were considered
reduced in the Expressing Intents component, with per-
formance falling below the normal range overall. This
overall expressive score is also inclusive of the subtest,
Ambiguous Sentences, which was also considered be-
low the normal range. This subtest examines a child’s
ability to interpret sentences with ambiguities arising
from multiple meaning words or phrases.
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Fig. 6. Case 3 at language testing (2 years 4 months post treatment):
Coronal and axial MRI scans indicating residual tumour in brainstem
and cerebellum post surgery and chemotherapy treatment.
3.2.6. Case 6
Case 6 was diagnosed at the age of 5 years 5 months
with a low grade cervicomedullary astrocytoma of the
lower brainstem/upper cervical spinal cord region (di-
agnosis MRI scan unavailable), following a 6 month
history of neck stiffness, and early morning vomiting
for 6 to 8 weeks. A head tilt was also noted for 7 months
prior, for which physiotherapy had been employed, in
addition to a slight dysdiadochokinesia and some diffi-
culties swallowing food. Hydrocephalus was not con-
sidered present. Partial resection and debulking of the
tumour was carried out 2 months following diagnosis.
Iatrogenic Cushing’s syndrome was noted following
surgery. A 10 week induction phase of chemotherapy
was commenced 3 months subsequent to surgery with a
weekly regime that utilized vincristine and carboplatin.
On completion symptoms of diplopia and signs of bilat-
eral VI cranial nerve palsy became evident. A planned
maintenance program over 12–18 months commenced,
while omitting one dose of carboplatin in Week 3 of
each cycle, due to these symptoms.
Language testing was carried out 3 years and 3–
4 months following diagnosis and 2 years 1–2 months
following treatment completion, at the age of 7 years
8 months. A MRI study taken over 2 weeks following
language testing showed little significant change of tu-
mour within the cervical cord from the medulla to the
level of T1 (see Fig. 10). Both general receptive and ex-
pressive language abilities as examined by the CELF-3
were noted to fall well within the normal range. Con-
frontation naming abilities were also considered to be
in the normal range for a child Case 6’s age, together
with receptive vocabulary skills on the PPVT-III. Case
6’s results are summarized in Table 4. Additionally,
Case 6 performed in the high to above normal range
across all assessments of high-level language abilities
and phonological awareness (see Table 5).
4. Discussion
The results of a group level analysis failed to demon-
strate a distinctive difference in the general language,
high-level language, or phonological awareness abil-
ities between a group of children who had received
treatment for brainstem tumour and their age and gen-
der matched peers. Except for some subtle high-level
language disturbances in the area of lexical structures
by Case 5, and isolated area of weakness in the liter-
acy skills of Case 2 measured by the Phoneme Detec-
tion subtest of the QUIL, all participants demonstrated
individual language abilities that were not considered
significantly different when compared to the norma-
tive data provided for each standardized assessment.
In certain instances, group means and some individual
performances were in fact above the normal range.
Prior to this investigation, specific reports of lan-
guage abilities following treatment for childhood brain-
stem tumour have not emerged,except for one case with
brainstem involvement documented as part of a larger
cohort of children with posterior fossa tumour inves-
tigated by Murdoch and Hudson-Tennent [38]. These
researchers documented similar findings to the current
group investigation, in reporting that no distinct, overt
pattern of language impairment was evident. Findings
obtained in the current study, in which larger numbers
were present and a more comprehensive test battery was
used than in testing the one participant with brainstem
involvement in the study documented by Murdoch and
Hudson-Tennent [38], suggests that language distur-
bances are not typically anticipated for this population
at least in the short term, despite treatments including
radiotherapy.
This in itself, however, is significant given the diver-
sity of the brainstem tumours represented in the chil-
dren in the present study, in size, specific location, char-
acteristics, and accompanying symptoms and result-
ing effects, as well as the often intensive and individ-
ual treatment programs employed. It is also suggested
that the prevalence of adverse effects such as language
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Fig. 7. Case 4 at diagnosis: Coronal and sagittal MRI scans indi-
cating a pontine astrocytoma arising at medullopontine angle pos-
teriorly. Extension into fourth ventricle and involvement of middle
cerebellar peduncle on right.
disturbances, previously attributed to treatment tech-
niques utilized in children treated for brain tumour may
have less impact on long-term language and cognitive
function of children treated for brainstem tumour than
observed in other populations [24,26]. However, it is
important to note that implications for children treated
with cranial or posterior fossa radiotherapymay present
many years following treatment, as documented effects
related to treatment for brain tumour in children have
been reported to occur up to as many as fourteen years
Fig. 8. Case 4 at language testing (6 years 3 months post treatment):
Sagittal MRI scan demonstrating tumour stability post surgery treat-
ment for brainstem tumour, with no progression or evidence of new
disease.
following treatment [30,32]. Considering that most
participants in the present study were only a few years
post treatment, the issue of any long term treatment im-
pact is as yet unexplored. More detailed investigation
of the language abilities of children treated for brain-
stem tumour in the long-term is therefore required.
It was anticipated that areas of language weakness in
the population of children treated for brainstem tumour
may include the cognitive processes of word-finding
and the motor processes of expression,which have been
reported to result from a disturbance to the neural loop
in the brainstem implicated in language function [31].
It has also been reported that tasks involving recall and
sorting may also be affected post brainstem injury [29].
However, as no overt deficits were noted across the
group analysis, disturbances to these processes termed
the language-learning loop by Leiner et al. [31], do
not appear to be evident. However, while word-finding
was not considered impaired in the present study (with
naming abilities of all participants measured by the
Hundred Pictures Naming Test found to be intact) it
must be acknowledged that Case 5 had a history of
residual persisting word-finding difficulties for which
speech pathology intervention was received. This his-
tory for Case 5 may therefore reflect some support for
this previous report by Leiner and colleagues [31]. Ad-
ditionally, while performance by Case 5 was also con-
sidered below the normal range on the Expressing In-
tents component of the TLC-E (Level) (including the
Ambiguous Sentences subtest), at a group level no pat-
terns of deficit emerged that were considered consistent
K.M. Docking et al. / Language outcomes subsequent to treatment of brainstem tumour in childhood 119
Fig. 9. Case 5 at language testing (2 years post treatment): Sagittal
T1 weighted MRI scan post radiotherapy and chemotherapy treat-
ment for brainstem glioma. Posterior fossa structures and supraten-
torial structures normal with no radiation necrosis.
with the hypothesized role of the brainstem in language
processing [31].
At the level of individual analysis, a specific area
of difficulty was noted in the performance of Case
5 on the expressive TLC-E subtest, Ambiguous Sen-
tences, which involves a lexical component. Therefore,
it was considered that Case 5 may have had some dif-
ficulty generating structures that involve lexical items.
It is also suggested that earlier word-finding difficul-
ties noted in the history of speech pathology inter-
vention for this case, may suggest the disturbance of
later lexical skills at a higher level. Other reports of
language deficits following acquired brain injury have
noted weaknesses in this area. A significant impairment
was noted by Docking et al. [15] in the lexical com-
ponent of an assessment of high-level language abili-
ties administered to a group of nine adolescents with
closed head injury in the area of linguistic humour. Ad-
ditionally, Hudson and Murdoch [25] reported severe
semantic-lexical deficits immediately post-treatment in
children treated with both surgery and central nervous
system radiation for a posterior fossa tumour,with some
cases demonstrating persistent difficulties.
Although Murdoch and Hudson-Tennent [38] re-
ported relatively intact language skills evidenced by
their one participant treated for brainstem tumour, a
number of subtle language characteristics were noted
in their study. Specifically, Murdoch and Hudson-
Fig. 10. Case 6 at language testing (6 months post treatment): Sagit-
tal T1 weighted MRI scan demonstrating post-operative changes in
posterior right aspect of upper cervical spine. Expansion and irreg-
ular enhancement within the cervical cord from medulla through to
approximately T1 level consistent with primary cervical cord astro-
cytoma.
Tennent [38] noted a reduction in language perfor-
mance in the obtained Speaking and Syntax Quotients
in relation to the Listening and Semantics Quotients in
their case, and was considered to be representative of
the difficulties experienced in the Sentence Combining
and Word Ordering subtests. Additionally, it was noted
by these authors that Subtest IV of the Token Test for
Children assessment was below the normal range. Fi-
nally, Murdoch and Hudson-Tennent [38] observed that
while the high-level language assessment, the Test of
Language Competence (TLC) was attempted, extreme
difficulty in understanding the requirements of each
subtest resulted in this assessment not being completed.
Therefore, in addition to some subtle language distur-
bances noted by Murdoch and Hudson-Tennent [38],
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it is unknown whether the difficulties encountered by
this child in relation to comprehension of the instruc-
tions of the TLC were in fact high-level language dis-
turbances that may have been consistent with the subtle
difficulties observed in Case 5 of the current study.
At a group level, performance on an assessment of
phonological awareness indicated pre-literacy skills of
the brainstem tumour group were within normal lim-
its, despite reports of later literacy difficulties in chil-
dren with brain trauma diagnosed with acquired apha-
sia (e.g. [1,13,21]). Even at an individual level, only
one isolated impairment was noted in Case 2. Although
most of Case 2’s scores ranged from falling within the
normal range to one standard deviation above the nor-
mal range, on the assessment of phonological aware-
ness skills (QUIL), performance on the Phoneme De-
tection subtest was slightly below the normative val-
ues. The Phoneme Detection subtest targets the abil-
ity to listen to the sounds in either the first, end, last,
or middle position within each of the four words pre-
sented for each item and to determine the odd one out.
Reduced performance on this task may, therefore, re-
flect a specific weakness in this area post brainstem tu-
mour. However, as this reduced score falls just outside
of the normal range, and appears particularly unchar-
acteristic given the performance on the remaining nine
subtests, it is also possible that external factors such
as fatigue and reduced concentration may explain this
performance. In addition, it is important to remember
that children who undergo treatment and/or manage-
ment for a chronic disease such as brain tumour often
experience long periods of hospitalization and recov-
ery, as well as often attending many follow-up medical
appointments in the period of time subsequent. These
factors highlight that schooling can often be interrupted
with the potential for the acquisition of specific phono-
logical awareness skills to be impacted. Consequently,
factors other than the brain tumour and its management
may be influencing performance on this subtest.
Although the present group of children treated for
brainstem tumour represent a heterogeneous popula-
tion, it was interesting to note that in the context of
those participants who presented with normal language
function, such findings were not consistent with any
specific pattern of treatment or duration post treatment.
Performance by Case 4 across assessments of language
and phonological awareness were noted to be within
the normal range, and in some cases above the normal
range. Intact language abilities in Case 4, who under-
went surgical excision as the only form of treatment for
an astrocytoma in the medullopontine angle, may have
demonstrated that although later intellectual outcomes
specifically related to surgery have been documented
by one author [23], late language changes in the case
are unlikely given that more than six years has elapsed
since treatment.
Case 6 also underwent surgical debulking of an astro-
cytoma in the lower brainstem. Subsequent chemother-
apy was also administered. However, language abili-
ties in this case were again not indicative of any dis-
turbances to this area. Therefore, reports of neurotox-
icity, encephalopathies (ranging from subclinical EEG
changes and drowsiness to coma and convulsions), en-
cephalomyelopathy,severe neurologic impairment,and
mild cerebral dysfunction associated with chemother-
apy [2,9,22], among others, were also not seen to im-
pact performance or were evident in either the gen-
eral or high-level language and phonological awareness
abilities in this case.
The effects of treatment for a childhood brain tu-
mour have been well documented and often suggest
far-reaching effects, particularly where combinations
of treatments have been employed. In the current study,
three of the six participants treated for brainstem tu-
mour (Cases 1, 2, and 4) received only one treatment
modality, while the remaining three (Cases 3, 5, and 6)
were treated with a combination of techniques.
While some participants received either radiother-
apy alone (Cases 1 and 2), surgery alone (Case 4), or
surgical intervention followed by chemotherapy (Case
6), it is of significance in terms of future research that
Cases 3 and Case 5 were the only participants treated
for brainstem tumour that underwent a combination of
both radiotherapy and chemotherapy. Of these, Case
5 was the only participant to demonstrate any form of
language disturbance in the area of high-level language.
As Case 3 did not undergo testing for high-level lan-
guage due to age, it is unknown whether Case 3 would
eventually exhibit high-level language disturbances as
observed in Case 5. It is noted that the only partici-
pant in the study by Murdoch and Hudson-Tennent [38]
with a tumour involving the brainstem, was also the
only participant to have received a combination of both
radiotherapy and chemotherapy.
As outlined, the chemotherapeutic drugs tamoxifen,
CCNU, and etoposide were administered to Case 5 over
a course of four years, with subsequent radical radio-
therapy to the brainstem using posterior oblique fields
(total dose of 54 Gy in 30 fractions over six weeks).
Treatment approaches utilizing a combination of ra-
diotherapy and chemotherapy have been reported to be
associated with significant late effects, including lan-
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guage deficits [28,39]. In fact, the number of treat-
ment modalities employed has been associated with
poorer intellectual function and achievement [10,17,
34]. Not only has the toxicity of chemotherapeutic
agents been documented to be enhanced by radiother-
apy [54], radiation in combination with chemotherapy
has also been reported to produce radiation necrosis,
parenchymal ischemia and infarction [3,6,22]. In ad-
dition, the particular sequence of radiotherapy follow-
ing chemotherapy as in Case 5, was reported by Sil-
verman and Thomas [48] to be an influencing factor of
neuropsychological sequelae following treatment.
The documented treatment effects of the specific
chemotherapeutic agents consisting part of Case 5’s
intensive treatment program administered over a total
period of four years include bone marrow suppression,
nausea and vomiting, diarrhoea, hair loss, mucositis,
hypotension, allergic reactions, infertility and renal,
pulmonary, hepatic, and cardiac toxicities [20,22,49,
54]. In particular, the agent etoposide has been associ-
ated with known neurotoxicity [20,22,49,54], and was
part of a treatment protocol for ten children in which
neuropsychological problems were documented in a
study by Sands et al. [42]. These children were ob-
served to have overall intelligence difficulties, particu-
larly in the areas of verbal reasoning and abstract visual
reasoning. As Case 5 was found to experience difficulty
in generating lexical structures in the current study, it
is possible that the chemotherapy drugs administered
together with radiotherapy may have been a contribut-
ing factor influencing function. Case 3 was also ad-
ministered the chemotherapeutic agent etoposide and
was found to have intact general language abilities, as
did Case 5. However, as previously highlighted, it is
undetermined if Case 3, who did not undergo testing
for high-level language, will eventually exhibit distur-
bances of high-level language similar to Case 5. While
considered a limitation for the present analysis, it is
highlighted that future research should included further
testing of Case 3 at an appropriate age.
A factor that may have also impacted performance in
the current study was Case 5’s age at the time of treat-
ment, as the impact of treatment on the young child is
well documented as being significantly increased com-
pared to older children (e.g. [50]). Chemotherapy was
commenced at the age of 20 months through to 4 years
of age, at which time radiotherapy was administered.
Age related effects are mostly reported in relation to the
known effects of radiotherapy, for which the impact is
often considered more serious in young children aged
under 3 to 4 years, who are considered more susceptible
to late neuropsychological damage [41]. Some authors
have even documented greater severity of impairment
and incidence of abnormal CT scans and neuropsy-
chological evidence in children up to 6 and 8 years of
age [22,47]. Therefore, difficulties in high-level lan-
guage demonstrated particularly by Case 5 may indeed
have been at least in part attributable to the combina-
tion of both radiotherapy and chemotherapy in the man-
agement of brainstem glioma and potential age effects.
Again, it is recognized that Case 3 was also under the
age of 3 years at diagnosis, and yet as this case was
not of appropriate age to undergo high-level language
assessments, it is unknown as to whether these higher
cognitive areas of language ability would be impacted
at a later stage.
Another factor unique to both Cases 3 and 5 was the
known presence of hydrocephalus. The indirect effect
of hydrocephalus on the brain’s structure and function is
a recognized cause of language deficits [24–26,35,36].
While Case 5 demonstrated specific areas of reduced
high-level language abilities, Case 3’s level of function
could not be assessed. However, the similar profiles
shared by these two cases, despite the younger age of
Case 3, may indicate the potential for later difficulties
for Case 3.
It must be acknowledged, however, that despite these
findings in context of the above factors, Case 5 exhib-
ited a long-term reduction of performance in just two
scores over many parameters of both general and high-
level language and phonological awareness. Therefore,
the influence of performance factors such as fatigue and
reduced concentration may have also impacted these
results and should not be discounted.
5. Conclusion
Despite some subtle high-level language distur-
bances evidenced by Case 5 in the area of generating
lexical structures, a group analysis of the high-level
language abilities of participants treated for brainstem
tumour revealed no significant differences when com-
pared to a group of individually matched peers. Simi-
larly, analysis revealed no group differences in phono-
logical awareness, although one participant revealed an
area of isolated weakness in a specific area of phonolog-
ical awareness. Overall, despite predictions of the po-
tential for language dysfunction based on neuroanatom-
ical connections [31], no overt language signs were
detected following treatment for brainstem tumour.
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While the current data did not reveal the presence
of any overt language impairments in children treated
for brainstem tumour, it is important to remember that
although the current assessment battery was extremely
comprehensive and covered more aspects of language
than that which had been previously addressed to
date [38], such measures are recognized to be basic
tests that may also not be sensitive enough to detect
subtle language changes. Therefore, it is impossible
to rule out the presence of subtle lexical and semantic
disturbances that may be identified by more sensitive
assessment techniques. However, it is reasonable to
suggest from current findings that at a functional level,
children treated for brainstem tumour exhibit adequate
general language abilities post treatment.
A closer examination of this population is still war-
ranted, however, due to the subtle difficulties that may
remain evident in the area of high-level language, as
suggested by Case 5’s data and the case study reported
by Murdoch and Hudson-Tennent [38]. Additionally,
further testing of Case 3 (who demonstrated similar
characteristics and received similar treatments to Case
5, despite not being of appropriate age to be admin-
istered high-level language assessments) would reveal
further clarification of the potential of the contributing
factors discussed in relation to Case 5. Factors such
as combination treatments consisting of both radiother-
apy and chemotherapy, as well as young age at time
of treatment were suggested to have contributed in the
present analysis.
Close monitoring of children treated for brainstem
tumour is also considered relevant due to the intensive
treatment that is often undergone particularly where
combinations of treatment are employed. Such moni-
toring needs to be ongoing, particularly in children un-
dergoing radiotherapy as part of their treatment, as neu-
ropsychological sequelae often increase concurrently
with the amount of time following radiation treatment.
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